Weight loss tends to be hard for most people and increased body weight tends to make people feel down or depressed and lack self-confidence. It can put people at an increased risk of heart disease, diabetes, stroke and can increase your risk of certain types of cancer. Tirzepatide is an FDA-approved medication generally used to help patients with type 2 diabetes manage their blood sugar levels. Still, it has also shown benefits for effective weight loss for individuals who are overweight or obese.

What is Tirzepatide?
Tirzepatide is a GIP and GLP-1 receptor agonist and works for weight loss by decreasing your appetite and slowing gastric emptying which will make you feel fuller for a longer period of time. Tirzepatide is administered once a week by injection.

Is Tirzepatide the same as Semaglutide?
No. While medications such as semglutdie focus solely on GLP-1 receptors, Tirzepatide utilizes both GLI and GLP-1 receptors to treat weight loss. The result is great weight loss.

TIRZEPATIDE BENEFITS:
• Reduces weight in many cases
• Works great with low-carb, high-
protein diet
• Improves confidence
• Can improve overall health
• Reduces appetite

What is tirzepatide prescribed for?
There are different brands of tirzepatide, such as Zepbound® & Mounjaro® which are FDA-approved for various conditions. Tirzepatide is an injectable prescription medication to improve glycemic control in adults with type 2 diabetes mellitus. While its main indication is for the treatment of type 2 diabetes, tirzepatide has been identified as a potential aid for weight loss in qualifying individuals. It works by reducing hunger, slowing gastric emptying and promoting a feeling of fullness after meals, which can lead to a decrease in overall caloric intake.

Clinical trials have highlighted its effectiveness in weight management when combined with diet and exercise. However, it should be used under the guidance of a healthcare professional, and the benefits and risks should be carefully evaluated on an individual basis. Additionally, a holistic approach to weight management, including diet and exercise, should be considered alongside medication when seeking sustainable weight loss. Studies on Tirzepatide have shown that nearly 75% of clinical trial participants lost up to 16% of their body weight.

Precautions/Side Effects:

As with any medication, tirzepatide may cause side effects. Common reactions include gastrointestinal issues such as nausea, vomiting, diarrhea, abdominal pain and constipation. Some individuals may experience more severe side effects, such as pancreatic inflammation, changes in vision or low blood sugar when used with other diabetes medications. It is not suitable for use in people with type 1 diabetes or diabetic ketoacidosis. Additionally, it is not approved for anyone under 18 years old.  It is crucial to discuss all potential risks with a healthcare provider before starting treatment with tirzepatide.

What does my BMI have to be to qualify for Tirzepatide?
Generally, individuals with a body mass index (BMI) of 30 or higher or a BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol, may qualify for Tirzepatide treatment.